NASDAQ$RDNT

Radnet Inc · Q1 2025 earnings

Q1 2025 earnings · · Before market open · Investor relations

Briefing

RadNet reported Q1 2025 revenue of $471.4M, a net loss of $37.9M, diluted EPS of $-0.51.

For Q1 2025, RadNet reported Revenue was $471.4M, net loss was $37.9M, diluted EPS was $-0.51. Management discusses operating trends, liquidity, and outlook in the quarterly filing.

  • Revenue $471.4M for Q1 2025.
  • Net loss $37.9M.
  • Diluted EPS $-0.51.

Headline financials

Total Revenue

$471M

Previous: $432M+9.2%
EPS (adj)

-$0.51

Previous: -$0.04-1175.0%
Capital Expenditures

-$52.6M

Previous: -$60.9M+13.6%
Net Income

-$37.9M

Previous: -$2.78M-1264.7%
Operating Income

-$24.1M

Previous: $11.3M-312.5%

Revenue & EPS history

Radnet · Revenue · Quarterly

$471M

Q1 2025+9.2%vs Q1 2024
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Forward guidance

Healthcare services outlook depends on patient volumes, reimbursement, and labor costs.

Tailwinds

  • Volume recovery and pricing where contracted.
  • Scale advantages in dialysis or behavioral health.

Headwinds

  • Treatment-day seasonality and flu impacts.
  • Regulatory and staffing cost pressure.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+0.8%

Avg return

Earnings day

+0.3%

Avg return

5 days after

+4.8%

Avg return

30 days after

51%

33 / 65 earnings

Positive

+22.5%

Q4 2020

Best reaction

-17.3%

Q1 2015

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.1%-10.1%-0.1%
Q4 2025+7.7%-13.1%-20.8%
Q3 2025+3.4%-4.0%-1.5%
Q1 2025+2.5%+9.7%+6.4%
Q4 2024-3.7%-7.8%-14.2%
Q3 2024+19.1%+9.7%+8.8%
Q2 2024+3.7%+3.6%+5.0%
Q1 2024+2.1%+6.2%+16.7%
Q4 2023+18.2%+26.4%+29.7%
Q3 2023+0.1%-2.1%+23.0%
Q2 2023+0.6%-0.3%-5.0%
Q1 2023-1.7%-6.2%+10.1%
Q4 2022+10.8%+19.1%+16.3%
Q3 2022-5.3%-4.6%+16.7%
Q2 2022+3.5%+5.4%-2.0%
Q1 2022-5.9%-5.9%+4.9%
Q4 2021-7.1%-7.6%-9.3%
Q3 2021-8.2%-9.0%-17.5%
Q2 2021-11.7%-19.9%-21.0%
Q1 2021+3.0%+1.1%+42.5%
Q4 2020+22.5%+26.2%+15.0%
Q3 2020+13.9%+11.0%+17.6%
Q2 2020-1.1%-2.8%-12.6%
Q1 2020+4.6%+3.7%+18.8%
Q4 2019-14.2%-46.9%-32.9%
Q3 2019-2.0%+11.5%+22.4%
Q2 2019+3.1%+3.6%-4.8%
Q1 2019+4.1%+4.3%-1.2%
Q4 2018+9.8%+2.4%-5.7%
Q3 2018-7.1%-14.2%-16.9%
Q2 2018+1.1%+1.1%-1.8%
Q1 2018-2.6%-2.6%-3.0%
Q4 2017+14.0%+22.2%+39.1%
Q3 2017-3.4%-5.3%-6.8%
Q2 2017-1.2%-1.2%+37.9%
Q1 2017+1.6%+8.7%+22.2%
Q4 2016-6.1%-1.7%+2.6%
Q3 2016-2.2%-2.9%-8.1%
Q2 2016+4.4%+5.2%+17.1%
Q1 2016-6.7%
Q4 2015-15.0%
Q3 2015-0.8%
Q2 2015+12.3%
Q1 2015-17.3%
Q4 2014-12.1%
Q3 2014-12.4%
Q2 2014+21.3%
Q1 2014+22.2%
Q4 2013+20.1%
Q3 2013-10.2%
Q2 2013-5.1%
Q1 2013-8.4%
Q4 2012+3.6%
Q3 2012-10.3%
Q2 2012+4.1%
Q1 2011+1.0%
Q1 2012+1.0%
Q4 2011-2.7%
Q4 2009-2.7%
Q3 2010-11.6%
Q3 2011-11.6%
Q4 2010+10.5%
Q2 2010+10.5%
Q2 2011+10.5%
Q1 2010-2.7%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro